Dr. Alehashemi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9000 Rockville Pike
Clinical Center 11C215
Bethesda, MD 20892Phone+1 301-451-7410
Education & Training
- National Institutes of Health2015 - 2018
- Hopkins Bloomberg School of Public HealthMPH, Epidemiology, 2015 - 2018
- Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2014
- Lincoln Medical and Mental Health CenterInternship, Internal Medicine, 2011 - 2012
- North Bristol NHS TrustCA, Medicine, 2007 - 2008
- Tehran University of Medical Sciences School of MedicineClass of 2005, MD
Certifications & Licensure
- DC State Medical License 2015 - 2021
- PA State Medical License 2014 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Distinguished Fellow Award American College of Rheumatology, 2018
- Research award American Association of Immunologists, 2018
- Research Award DC Rheumatism Society, 2016
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsEmerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus.Raphaela Goldbach-Mansky, Sara Alehashemi, Adriana A de Jesus
Nature Reviews. Rheumatology. 2025-01-01 - Regression Approaches to Assess Effect of Treatments That Arrest Progression of Symptoms.Ana M Ortega-Villa, Martha C Nason, Michael P Fay, Sara Alehashemi, Raphaela Goldbach-Mansky
Statistics in Medicine. 2024-11-30 - 2 citationsNormalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I Interferonopathies.Genia Kretzschmar, Laura Piñero Páez, Ziyang Tan, Jun Wang, Laura Gonzalez
Journal of Clinical Immunology. 2024-10-23
Abstracts/Posters
- PROTEOMICS AND RNA SEQUENCING APPROACHES HIGHLIGHT THE ROLE OF ENDOTHELIAL CELL DYSREGULATION IN IL-1 AND IFN MEDIATED AUTOINFLAMMATORY DISEASES, NOMID AND CANDLES Alehashemi, M Garg, B Sellers, A De Jesus, A Biancotto, J Lack, R Goldbach-Mansky, Annals of the Rheumatic Diseases, 6/1/2020
- Autoinflammatory Eye Disease Due to NLRP3 Inflammasome-Associated Mutations and Excessive IL-1β Responses may be Driven by Ocular Exposure to CommensalsJay Siak, Anthony J St Leger, Mary Mattapallil, M Teresa Magone, Wadih Zein, Sara Alehashemi, Kumarkrishna Raychaudhuri, Guangxun Meng, Ivan Fuss, Warren Strober, Raph..., The Journal of Immunology, 5/1/2020
- Preliminary Analysis of Hearing Loss in a Neonatal-Onset Multisystem Inflammatory Disease (NOMID) Cohort Followed over a Mean of 10 YearsSara Alehashemi, Megha Garg, Kelly King, Chris Zalewski, Adriana de Jesus, John Butman, Jonah Eisenberg, Carmen Brewer, Rey Kim, Raphaela Goldbach-Mansky, ARTHRITIS & RHEUMATOLOGY, 10/1/2019
- Join now to see all
Press Mentions
- Rheumatologist, Researcher & Badminton PlayerNovember 24th, 2020
- Health and socioeconomic outcomes in a NOMID cohortNovember 24th, 2020
Professional Memberships
- Member
Other Languages
- Farsi, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: